Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.

Medicine and Dentistry

• Nesiritide 100%
• Infusion 60%
• Patient 60%
• Heart Failure 50%
• Outpatient 50%
• Ethinylestradiol Plus Megestrol Acetate 50%
• Cardiovascular System 30%
• Association 30%
• Heart 30%
• Placebo 30%
• Follow up 20%
• New York Heart Association Class 20%
• Device Therapy 20%
• Symptom 20%
• Morbidity 10%
• Disease Management 10%
• Log Rank Test 10%
• Dyspnea 10%
• Adverse Event 10%
• Cardiomyopathy 10%
• Ejection Fraction 10%
• Combination Therapy 10%
• Hypotension 10%
• Kidney Function 10%
• Hazard Ratio 10%
• Cause of Death 10%
• Creatinine Clearance 10%
• Lung Congestion 10%
• Mortality 10%
• Hospital 10%
• Inpatient 10%
• Motivation 10%
• Experience 10%
• Amaurosis 10%
• Death 10%
• Medical Device 10%

INIS

• patients 70%
• infusion 60%
• heart failure 50%
• kidneys 30%
• therapy 20%
• devices 20%
• management 20%
• death 20%
• new york 20%
• symptoms 20%
• data 10%
• risks 10%
• hospitals 10%
• diseases 10%
• cities 10%
• interventions 10%
• mortality 10%
• safety 10%
• morbidity 10%
• hypotension 10%
• hazards 10%
• clearance 10%
• creatinine 10%
• kansas 10%